Actively Recruiting

Age: 18Years +
All Genders
NCT05081024

Establishing a ctDNA Biomarker to Improve Organ Preserving Strategies in Patients With Rectal Cancer

Led by OHSU Knight Cancer Institute · Updated on 2025-09-25

50

Participants Needed

2

Research Sites

260 weeks

Total Duration

On this page

Sponsors

O

OHSU Knight Cancer Institute

Lead Sponsor

N

Natera, Inc.

Collaborating Sponsor

AI-Summary

What this Trial Is About

This study measures the levels of circulating tumor DNA (ctDNA) in patients with stage II-III rectal cancer before, during, and after treatment to find out if the presence or absence of ctDNA in patient's blood using the Signatera test can be used to gauge how different treatments may affect rectal cancer. ctDNA is DNA from the rectal cancer that is circulating in the blood. The purpose of this study is to understand if the way rectal tumors respond to standard treatment can be associated with varying levels of ctDNA.

CONDITIONS

Official Title

Establishing a ctDNA Biomarker to Improve Organ Preserving Strategies in Patients With Rectal Cancer

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Participant must provide written informed consent before any study-specific procedures or interventions are performed
  • Participants aged 6 18 years
  • Pathologically-confirmed stage II or III primary adenocarcinoma of the rectum: T3N0M0 - T4bN2M0
Not Eligible

You will not qualify if you...

  • Has radiologic evidence of distant metastases at the time of screening/enrollment
  • Has received prior treatment for their rectal adenocarcinoma
  • Requires or has received blood transfusion within 1 month of study enrollment

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

OHSU Knight Cancer Institute

Portland, Oregon, United States, 97239

Actively Recruiting

2

Fred Hutch

Seattle, Washington, United States, 98109

Actively Recruiting

Loading map...

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Establishing a ctDNA Biomarker to Improve Organ Preserving Strategies in Patients With Rectal Cancer | DecenTrialz